BE820775A - Compositions therapeutiques a base d'agents contenant un azote tertiaire et procede de preparation - Google Patents

Compositions therapeutiques a base d'agents contenant un azote tertiaire et procede de preparation

Info

Publication number
BE820775A
BE820775A BE149276A BE149276A BE820775A BE 820775 A BE820775 A BE 820775A BE 149276 A BE149276 A BE 149276A BE 149276 A BE149276 A BE 149276A BE 820775 A BE820775 A BE 820775A
Authority
BE
Belgium
Prior art keywords
preparation
therapeutic compositions
compositions based
agents containing
tertiary nitrogen
Prior art date
Application number
BE149276A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE820775A publication Critical patent/BE820775A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE149276A 1973-10-12 1974-10-07 Compositions therapeutiques a base d'agents contenant un azote tertiaire et procede de preparation BE820775A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/406,013 US3966949A (en) 1973-10-12 1973-10-12 Pharmaceutical compositions and preparing same

Publications (1)

Publication Number Publication Date
BE820775A true BE820775A (fr) 1975-02-03

Family

ID=23606175

Family Applications (1)

Application Number Title Priority Date Filing Date
BE149276A BE820775A (fr) 1973-10-12 1974-10-07 Compositions therapeutiques a base d'agents contenant un azote tertiaire et procede de preparation

Country Status (9)

Country Link
US (1) US3966949A (fr)
BE (1) BE820775A (fr)
CA (1) CA1043260A (fr)
DE (1) DE2448119C2 (fr)
FR (1) FR2247257B1 (fr)
GB (1) GB1437880A (fr)
NL (1) NL184197C (fr)
PH (1) PH10451A (fr)
ZA (1) ZA745756B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR245888A1 (es) * 1989-01-23 1994-03-30 Merrell Pharma Inc Procedimiento para la preparacion de una composicion farmaceutica liquida de derivados de piperidinoalcanol.
DE4023241A1 (de) * 1990-07-21 1992-01-23 Knoll Ag Stabile wirkstoff-formulierung
AU701042B2 (en) * 1995-02-28 1999-01-21 Aventisub Llc Pharmaceutical composition for piperidinoalkanol compounds
US5574045A (en) * 1995-06-06 1996-11-12 Hoechst Marion Roussel, Inc. Oral pharmaceutical composition of piperidinoalkanol compounds in solution form
EE04294B1 (et) * 1997-08-26 2004-06-15 Hoechst Marion Roussel, Inc. Farmatseutiline kompositsioon piperidinoalkanooldekongestandi kombineerimiseks
WO2003053410A1 (fr) * 2001-12-20 2003-07-03 Alpex Pharma Sa Compositions particulaires
AU2004253334A1 (en) * 2003-07-02 2005-01-13 Astrazeneca Ab Metabolite of quetiapine
US20080234343A1 (en) * 2004-03-24 2008-09-25 Takeda Pharmaceutical Company Preparation with Elevated Content
JP2009516708A (ja) * 2005-11-18 2009-04-23 アストラゼネカ・アクチエボラーグ 液体製剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1192812A (en) * 1966-05-20 1970-05-20 American Cyanamid Co 2-Chloro-11-(1-Piperazinyl)Dibenz[b,f]-[1,4]Oxazepine, Non-Toxic Acid Addition Salts thereof, and Therapeutic Compositions containing said Oxazepine or Salts
DE1795362A1 (de) * 1968-09-19 1972-01-05 Boehringer Mannheim Gmbh Basische AEther und Verfahren zur Herstellung derselben
US3652658A (en) * 1969-01-23 1972-03-28 Josef Fried Ester derivatives of bis(p-(amino-lower alkyleneoxy)phenyl)alkanols
US3683084A (en) * 1969-02-06 1972-08-08 Jean Schmutz Basically substituted heterocycles as anti-emetics

Also Published As

Publication number Publication date
NL7412644A (nl) 1975-04-15
FR2247257B1 (fr) 1977-11-04
FR2247257A1 (fr) 1975-05-09
ZA745756B (en) 1975-10-29
NL184197C (nl) 1989-05-16
DE2448119C2 (de) 1984-03-29
NL184197B (nl) 1988-12-16
DE2448119A1 (de) 1975-04-17
US3966949A (en) 1976-06-29
PH10451A (en) 1977-03-31
CA1043260A (fr) 1978-11-28
GB1437880A (en) 1976-06-03
AU7314974A (en) 1976-03-18

Similar Documents

Publication Publication Date Title
BE842329A (fr) Nouveaux esters-17b d'oestradiol et compositions therapeutiques renfermant des esters-17b d'oestradiol
BE810925A (fr) Presentoir d'articles
BE890028A (fr) Poudre a base de sel d'addition d'acide de bacampicilline-micro-encapsule et composition pharmaceutique la contenant
IT1062991B (it) Profumo a base di esteri alchil-cicloalchilici dell'acido carbonico sua produzione e composizione di profumi che lo contiene
BE833394A (fr) Composition pharmaceutique destinee a faciliter l'accouchement
BE820775A (fr) Compositions therapeutiques a base d'agents contenant un azote tertiaire et procede de preparation
BE802700A (fr) Nouvelles compositions pharmaceutiques a base d'acide glycyrrhetinique
FR2343030A1 (fr) Composition d'elastomere contenant un mercaptosiloxane et procede de preparation d'un elastomere
FR2489151B1 (fr) Production d'hormone luteinisante humaine
BE861888A (fr) Compositions contenant un derive de l'acide salicyclique et applications a titre de medicament
FR2488135B1 (fr) Composition pharmaceutique a base de propylene-glycol et d'acetaminophene
JPS525768A (en) Novel propargyll22phenylaminoo imidazolinee*2* * acid adduct thereof * pharmaceutical agent containing same and production thereof
FR2495635B1 (fr) Production d'urokinase humaine
BE779724R (fr) Nouveaux sels contenant de l'azote et du
FR2301244A1 (fr) Nouvelle preparation pharmaceutique contenant du glutamate ou de l'aspartate de magnesium
FR2307541A1 (fr) Medicament a base d'un polypeptide
JPS51131888A (en) Production of novel 99 alkylaminooerythromycine and pharmaceutical composition containing same
FR2340095A1 (fr) Nouvelle composition therapeutique a base d'acide chenodesoxycholique
FR2323397A1 (fr) Composition medicinale a base d'hormones
JPS52122385A (en) Production of novel benzodiazepines and salts thereof and pharmaceutical composition
FR2315530A1 (fr) Composition phosphorescente et son procede d'obtention
FR2329281A1 (fr) Nouveaux 6,8-dioxamorphinanes n-substitues et composition pharmaceutique les contenant
FR2313937A1 (fr) Medicament a base de 5' thioethers de l'adenosine
BE835913A (fr) Composes polycycliques contenant de l'azote, et leur procede de preparation
LU77928A1 (fr) Procede de preparation de nouvelles organoprostaglandines et d'un medicament les contenant

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: MERRELL DOW PHARMACEUTICALS INC.

Effective date: 19941007